Clinicopathological features and survival outcomes of luminal-like breast tumors with estrogen receptor loss at metastatic recurrence: A case-control study-Reference-Cited by-同舟云学术

Clinicopathological features and survival outcomes of luminal-like breast tumors with estrogen receptor loss at metastatic recurrence: A case-control study

Published:2023-12 Issue: Volume:195 Page:113397
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Morganti Stefania,Marra Antonio^ORCID,Gandini Sara,Ascione Liliana^ORCID,Ivanova Mariia^ORCID,Venetis Konstantinos^ORCID,Sajjadi Elham,Zagami Paola^ORCID,Giugliano Federica^ORCID,Taurelli Salimbeni Beatrice,Berton Giachetti Pier Paolo Maria,Corti Chiara^ORCID,De Camilli Elisa,Curigliano Giuseppe^ORCID,Fusco Nicola^ORCID,Criscitiello Carmen^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference27 articles.

1. Breast cancer;Loibl;Lancet.,2021

2. Supervised risk predictor of breast cancer based on intrinsic subtypes;Parker;J Clin Oncol,2009

3. The St. Gallen surrogate classification for breast cancer subtypes successfully predicts tumor presenting features, nodal involvement, recurrence patterns and disease free survival;Vasconcelos;Breast,2016

4. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013;Goldhirsch;Ann Oncol,2013

5. Intrinsic subtypes and gene expression profiles in primary and metastatic breast cancer;Cejalvo;Cancer Res,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nomograms to Predict Individual Potential Benefit from Targeted Therapy for patients with lymph node positive Luminal B (HER2-) breast cancer;2024-01-17